⌘K
Loading ticker…
As of 2026-08-24, Medpace Holdings, Inc. Common Stock (MEDP) has a 3-month relative strength percentile of 92 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 60. The current market Stance is 47.8 (Neutral). Sector: Industrials, ranked 6 of 11. Average daily range 3.1%, relative volume 0.70×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
MEDP is held by 56 ETFs as of May 2026. Top owner: VHT at 0.16% weight, $30M notional. Top 3 carry $79M.
Held by 177 ETFs · $2.4B across latest filings · largest weight 3.09% (ALIL).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VHTVanguard Health Care ETF | 0.16% | $30M | — |
| SCHMSchwab U.S. Mid-Cap ETF | 0.19% | $27M | −0.01 pp |
| SCHGSchwab U.S. Large-Cap Growth ETF | 0.03% | $21M | — |
| VONGVanguard Russell 1000 Growth ETF | 0.03% | $16M | — |
| IVOO |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.29% |
| $16M |
| — |
| SCHXSchwab U.S. Large-Cap ETF | 0.01% | $10M | — |
| IVOG | 0.55% | $10M | −0.01 pp |
| QQQJ | 0.59% | $7M | −0.04 pp |
| FNDA | 0.07% | $6M | — |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $6M | — |
Showing 10 of 56 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MEDP Jan avg: 2.00% median: 3.89% win: 75% σ: 4.62% n: 4 2022-04-12 → 2026-07-31 | MEDP Feb avg: -1.17% median: -9.28% win: 25% σ: 25.88% n: 4 2022-04-12 → 2026-07-31 | MEDP Mar avg: -0.49% median: -0.67% win: 50% σ: 5.72% n: 4 2022-04-12 → 2026-07-31 | MEDP Apr avg: -5.01% median: -3.91% win: 40% σ: 9.38% n: 5 2022-04-12 → 2026-07-31 | MEDP May avg: 2.51% median: 3.41% win: 60% σ: 4.95% n: 5 2022-04-12 → 2026-07-31 | MEDP Jun avg: 10.40% median: 6.60% win: 100% σ: 6.36% n: 5 2022-04-12 → 2026-07-31 | MEDP Jul avg: 11.33% median: 8.97% win: 80% σ: 15.80% n: 5 2022-04-12 → 2026-07-31 | MEDP Aug avg: -0.50% median: -0.18% win: 50% σ: 11.41% n: 4 2022-04-12 → 2026-07-31 (current) | MEDP Sep avg: -0.46% median: 0.22% win: 50% σ: 9.17% n: 4 2022-04-12 → 2026-07-31 | MEDP Oct avg: 12.34% median: 6.99% win: 75% σ: 20.94% n: 4 2022-04-12 → 2026-07-31 | MEDP Nov avg: 3.95% median: 4.85% win: 75% σ: 7.60% n: 4 2022-04-12 → 2026-07-31 | MEDP Dec avg: 1.69% median: -0.63% win: 50% σ: 8.13% n: 4 2022-04-12 → 2026-07-31 |